Response to Comments: Transurethral Waterjet Ablation of the Prostate

This response-to-comments policy clarifies that decisions regarding transurethral waterjet ablation of the prostate are based on the best available published clinical evidence, prioritized per CMS Program Integrity Manual (CMS Pub. 100‑08 Chapter 13). Anecdotal or unpublished information has limited influence, and MACs may consolidate, redact, or withhold portions of submitted comments during the review and publication process.

"Anecdotal or unpublished information not subject to peer review has limited influence on policy determinations and will not carry the same weight as published peer‑reviewed evidence."

Sign up to see full coverage criteria, indications, and limitations.